CDX2 and autoimmune thrombocytopenic purpura: A study conducted on a Turkish cohort assessed the functional promoter polymorphism CDX2 (rs11568820), along with the previously mentioned polymorphisms (FokI, BsmI, ApaI, and TaqI), exploring their potential involvement in the development of ITP.